172
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes

, , , , , , , , & show all
Pages 3929-3938 | Published online: 23 Jul 2012

References

  • SaeedHMAbdel-FattahYRGoharYMElbazMAPurification and characterization of extracellular Pseudomonas aeruginosa urate oxidase enzymePol J Microbiol200453455215330267
  • PasutGSergiMVeroneseFMAnti-cancer PEG-enzymes: 30 years old, but still a current approachAdv Drug Deliv Rev200860697817869378
  • BomalaskiJSHoltsbergFWEnsorCMClarkMAUricase formulated with polyethylene glycol (uricase-PEG 20): biochemical rationale and preclinical studiesJ Rheumatol2002291942194912233890
  • FreitasDSSpencerPJVassaoRCAbrahao-NetoJBiochemical and biopharmaceutical properties of PEGylated uricaseInt J Pharm201038721522219969053
  • O’LoughlinJABruderJMLysaghtMJDegradation of low molecular weight uremic solutes by oral delivery of encapsulated enzymesASAIO J20045025326015171478
  • YasudaYFujitaTTakakuraYHashidaMSezakiHBiochemical and biopharmaceutical properties of macromolecular conjugates of uricase with dextran and polyethylene glycolChem Pharm Bull199038205320561702692
  • MagnaniMManciniUBianchiMFaziAComparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradationAdv Exp Med Biol19923261891941295305
  • SessaGWeissmannGIncorporation of lysozyme into liposomes. A model for structure-linked latencyJ Biol Chem1970245329533015459633
  • EugeniaMCruzMGasparMMBarbaraMMartinsFCorvoMLLiposomal superoxide dismutases and their use in the treatment of experimental arthritisNejatDMethods in Enzymology, LiposomesLondonAcademic Press2005391395413
  • LiMHanfordMJKimJWPeeplesTLAmyloglucosidase enzymatic reactivity inside lipid vesiclesJ Biol Eng20071418271982
  • BudaiMChapelaPGrófPPhysicochemical characterization of stealth liposomes encapsulating an organophosphate hydrolyzing enzymeJ Liposome Res20091916316819235545
  • TanQZhangJZhangLNot only anticancer drugs but also enzymes can be encapsulated in either micelle or other carrier for the treatment of cancerMed Hypotheses20107439639719762160
  • WaldePIchikawaSEnzymes inside lipid vesicles: preparation, reactivity and applicationsBiomol Eng20011814317711576871
  • YoshimotoMStabilization of enzymes through encapsulation in liposomesMethods Mol Biol200167991820865384
  • TanQYWangNYangHCharacterization, stabilization and activity of uricase loaded in lipid vesiclesInt J Pharm201038416517219782743
  • TanQYWangNYangHPreparation and characterization of lipid vesicles containing uricaseDrug Deliver2010172837
  • TiourinaOSharfTBalkinaAInteraction of the water-soluble protein aprotinin with liposomes: gel-filtration, turbidity studies, and 31P NMR studiesLiposome Res200313213229
  • GeorgiouCDGrintzalisKZervoudakisGPapapostolouIMechanism of Coomassie brilliant blue G-250 binding to proteins: a hydrophobic assay for nanogram quantities of proteinsAnal Bioanal Chem200839139140318327568
  • ZhangJQZhangZRYangHTanQYQinSRQiuXLLyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: in vitro and in vivo studiesPharm Res20052257358315846465
  • ZhaoYZhaoLYangGTaoJBuYLiaoFCharacterization of a uricase from Bacillus fastidious A.T.C.C. 26904 and its application to serum uric acid assay by a patented kinetic uricase methodBiotechnol Appl Biochem200645758016689679
  • HuisingaWTelgmannRWulkowMThe virtual laboratory approach to pharmacokinetics: design principles and conceptsDrug Discov Today20061180080516935747
  • ZhangCYangXLFengJEffects of modification of amino groups with poly(ethylene glycol) on a recombinant uricase from Bacillus fastidiosusBiosci Biotechnol Biochem2010741298130120530883
  • AllisonAGGregoriadisGLiposomes as immunological adjuvantsNature19742522524424229
  • RongenHAHBultAVanBWPLiposomes and immunoassaysJ Immunol Methods19972041051339212829
  • LasicDDNovel applications of liposomesTrends Biotechnol1998163073219675915
  • ShermanMRSaiferMGWilliamsLDMountain View Pharmaceuticals, Inc, assigneeAggregate-free urate oxidase for preparation of non-immunogenic polymer conimmunogenic polymer conjugates United States patent US 6783965 B1.8312004
  • KayeSBLiposomes – Problems and promise as selective drug carriersCancer Treat Rev1981827507018681
  • MulhbacherJMcGeeneyKIspas-SzaboPLenaertsVMateescuMAModified high amylose starch for immobilization of uricase for therapeutic applicationBiotechnol Appl Biochem20023616317012452799
  • NishimuraHMatsushimaAInadaYImproved modification of yeast uricase with polyethylene glycol, accompanied with nonimmunoreac-tivity towards anti-uricase serum and high enzymic activityEnzyme19812649537194181
  • ChenRHAbuchowskiAVanETPalczukNCDavisFFProperties of two urate oxidases modified by the covalent attachment of poly(ethylene glycol)Biochim Biophys Acta19816602932987197160
  • SchiavonOCalicetiPFerrutiPVeroneseFMTherapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly(ethylene glycol) and poly(N-acryloylmorpholine)Farmaco20005526426910966157
  • ConstantinidesPPChaubalMVShorrRAdvances in lipid nanodispersions for parenteral drug delivery and targetingAdv Drug Deliv Rev20086075776718096269
  • GargMDuttaTJainNKReduced hepatic toxicity enhanced cellular uptake and altered pharmacokinetics of stavudine loaded galactosylated liposomesEur J Pharm Biopharm200767768517303396